Expert group deliberates on strategy to ensure COVID vaccine availability, delivery mechanism

PTI

File photo: Corona vaccine

File photo: Corona vaccine

The national expert group on vaccine administration for COVID-19 met for the first time on August 12 to ensure the availability of the COVID-19 vaccine and its delivery mechanism.

The meeting was chaired by Dr V K Paul, a member of Niti Aayog along with Union Health Secretary as co-chair. The committee also advised all the states not to chart separate pathways of procurement, according to the health ministry.

The expert group deliberated on conceptualization and implementation mechanisms for creation of a digital infrastructure for inventory management and delivery mechanism of the vaccine including tracking of vaccination process with particular focus on last mile delivery. They discussed on broad parameters guiding the selection of COVID-19 vaccine candidates for the country and sought inputs from the standing Technical sub-committee of National Technical Advisory Group on Immunization (NTAGI).

“The group delved on the procurement mechanisms for COVID-19 vaccine, including both indigenous and international manufacturing along with guiding principles for prioritization of population groups for vaccination,” the health ministry said.

The expert group discussed the financial resources required for procurement of the COVID-19 vaccine and various options of financing the same. Available options in terms of delivery platforms, cold chain and associated infrastructure for roll out of COVID-19 vaccination were also taken up.

The meeting also discussed strategy and follow-up action on all possible scenarios to ensure equitable and transparent delivery of the vaccine.

Issues related to vaccine safety and surveillance were taken up and strategy for community involvement through transparent information and awareness creation were discussed, the ministry added.

India’s support to its key neighbors and development partner countries for COVID-19 vaccines was also discussed.

“The expert group discussed that India will leverage domestic vaccine manufacturing capacity and will also engage with all international players for early delivery of vaccines not only in India but also in low and middle income countries,” the ministry said.

PTI